Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. News
  7. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed Quote. Delayed NSE India Stock Exchange - 01/26 11:40:07 pm
797.7 INR   -1.28%
01/25Sun Pharmaceutical Industries' Board to Consider Interim Dividend for Fiscal 2022
MT
01/25SUN PHARMACEUTICAL INDUSTRIES : Dividend Updates
PU
01/23SUN PHARMACEUTICAL INDUSTRIES : Loss of Share Certificates
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nomura Adjusts Sun Pharmaceutical Industries' Price Target to 1,010 Indian Rupees From 969 Indian Rupees, Keeps at Buy

11/04/2021 | 01:17am EST


© MT Newswires 2021
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
01/25Sun Pharmaceutical Industries' Board to Consider Interim Dividend for Fiscal 2022
MT
01/25SUN PHARMACEUTICAL INDUSTRIES : Dividend Updates
PU
01/23SUN PHARMACEUTICAL INDUSTRIES : Loss of Share Certificates
PU
01/19Sun Pharma to announce third quarter results on January 31, 2022
AQ
01/13Indian Benchmarks Extend Gains on Thursday; Tata Steel Jumps 6%
MT
01/04Indian Indices Extend Gains on Tuesday; NTPC Jumps 6%
MT
2021Sun Pharma receives DCGI approval for Molxvir (Molnupiravir) in India
AQ
2021Indian Indices Close in Red Midweek; Eicher Motors Climbs 3%
MT
2021Sun Pharmaceutical Industries to Set Up Manufacturing Facility in Andhra Pradesh, India
MT
2021Indian Indices Extend Gains on Tuesday; Asian Paints Climbs 3%
MT
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Financials
Sales 2022 384 B 5 107 M 5 107 M
Net income 2022 70 404 M 937 M 937 M
Net cash 2022 93 095 M 1 240 M 1 240 M
P/E ratio 2022 27,0x
Yield 2022 0,64%
Capitalization 1 939 B 25 888 M 25 814 M
EV / Sales 2022 4,81x
EV / Sales 2023 4,25x
Nbr of Employees 37 000
Free-Float 81,7%
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | SUNPHARMA | INE044A01036 | MarketScreener
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Last Close Price 808,05 INR
Average target price 924,30 INR
Spread / Average Target 14,4%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Israel Makov Non-Executive Chairman
Atanu Roy SVP & Chief Information Officer
Davinder Singh Executive Vice President-Global Operations